CRUK Consent Forms – Bladder cancer immunotherapy regimens

Urology – Bladder cancer immunotherapy regimens have been updated and added to the CRUK website.

A new form for Nivolumab has been added.

Revalidation of the remaining regimen specific consent forms are in progress and will be updated in due course.

All forms can be found at www.cruk.org/sact_consent.

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

Any questions, please do let me know.

Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

Latest News

By BOPA Education & Training Subcommittee on 13th December 2025

Education and Training Webinar – AI uses cases in Cancer Pharmacy

17th December 2025 13:00-14:00 GMT REGISTER for the Webinar HERE Available for both PAID members and FREE associates The BOPA Education and Training Subcommittee would like to invite you to one…

Read article
By BOPA E&T Subcommittee on 9th December 2025

BOPA Introduction to Cancer Course, Scotland, March 2026 – registration now OPEN!

The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…

Read article
By BOPA Research Committee on 7th December 2025

BOPA-PRUK Research Award – NOW OPEN for Applications 2026

The 2026 PRUK funding round launched on 24th November 2025 and will close at 1pm on 25th March 2026.  BOPA-PRUK Research Award – NOW OPEN for Applications 2026 This award provides pharmacy professionals…

Read article
By BOPA Research Subcommittee on 2nd December 2025

AI in Oncology Survey

The Research Subcommittee would like to invite members to participate in this MPharm research project. Please find further details below. I am a 4th year pharmacy student at Kingston University…

Read article